Boan Biologics Announces CDE Acceptance of IND Application for BA1203, a Masked PD-1/IL-2 Antibody-Cytokine Prodrug

Disclaimer: The market involves risks, and investment should be approached with caution. This article is published based on a third-party database and does not represent the views of Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. In case of discrepancies, please refer to the actual announcements. For inquiries, please contact biz@staff.sina.com.cn.

Responsible Editor: Xiaolang Express